Faculty Opinions recommendation of Resumption of imatinib to control metastatic or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib (RIGHT): a randomised, placebo-controlled, phase 3 trial.
2020 ◽
Vol 21
(7)
◽
pp. 923-934
◽
2013 ◽
Vol 14
(12)
◽
pp. 1175-1182
◽
2008 ◽
Vol 44
(4)
◽
pp. 501-509
◽
2010 ◽
Vol 11
(10)
◽
pp. 942-949
◽